| 1 |
27519631 | Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro study. | 2016 Dec 5 |
1 |
| 2 |
23624423 | 4-Hydroxytamoxifen-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells. | 2013 Jul 5 |
2 |
| 3 |
22295107 | Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signaling. | 2012 |
1 |
| 4 |
22425989 | The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells. | 2012 Apr 6 |
1 |
| 5 |
20086172 | The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. | 2010 Feb 1 |
2 |
| 6 |
19153601 | Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. | 2009 Mar 4 |
2 |
| 7 |
16239258 | The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. | 2006 Mar |
1 |
| 8 |
16835357 | 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. | 2006 Oct |
1 |